Signal from the log
Graph AI
13,3 M$ · Series A · United States · Health software
Éditeur de Pleasanton, en Californie, fondé en 2024, qui automatise la pharmacovigilance : réception des signalements d'effets indésirables, tri, puis instruction du dossier. La société revendique un temps de traitement passé de plus de trois heures à moins de dix minutes sur ses déploiements en production.
Verified
Announced on , logged by the watch of 10 September 2026.
- Operation
- Funding round
- Announced amount
- 13,3 M$
- Stage
- Series A
- Country
- United States
- Sector
- Health software
What the log says
Editorial note, in French
Communiqué ouvert, montant relu et fonds nommés.
The investors
Led by Insight Partners
Provenance
Source prnewswire
Logged on 10 September 2026
Description Written in French during the watch run. Written during the watch run, after reading the issuer's press release or the source article.
Verification Amounts and fund names were double checked against the issuer's press release or an official filing.
What this status means
Verified The press release was opened: amount double checked, funds named. The article remains to be written.
The rule A signal is never removed from the log. A round set aside stays readable with its reason, because a collection you cannot reread is a collection you cannot correct.